Hazra, M. “A Rational Pharmacotherapeutic Study of Comparative Safety Among Topical Anti-Acne 1% Nadifloxacin Monotherapy, 0.1% Adapalene Monotherapy, 0.025% Tretinoin Monotherapy, 1% Nadifloxacin and 0.1% Adapalene Combination Therapy and 1% Nadifloxacin and 0.025% Tretinoin Combination Therapy, in Mild to Moderate Acne Vulgaris, in Tertiary Care Hospitals”. International Journal of Basic & Clinical Pharmacology, vol. 8, no. 9, Aug. 2019, pp. 1959-65, doi:10.18203/2319-2003.ijbcp20193662.